The North East Innovation Lab, part of Newcastle Hospitals has been featured in the national and international specialist media.
New York based global publication Genomeweb spoke to Dr John Tyson, head of the lab about its work in ultimately protecting communities from current, and future virus and health threats.
The article explores the lab’s work in supporting diagnostic developers, evaluating and validating new diagnostic testing for Covid-19 and other diseases, and providing samples for these studies through its biobank. The articl also features the lab’s partners Kromek and QuantumDX
You can sign up to read the article here.
The technologies the lab assesses are at various stages of development, from early concepts through to devices that are market-ready. Through tailored, scientific assessment, clients are provided with detailed information about the performance and accuracy of their products which can also be tailored as evidence for regulatory approvals. The team also advises clients on the best approach to take for an effective evaluation or validation process.
National specialist media Pathology in Practice Magazine and the Clinical Services Journal have also featured Dr Tyson talking about how the work of the lab is expanding from Covid to assessing and evaluating technologies for other virus threats.
Read more here.
